Yamana H

Title : Treatment Duration of Cholinesterase Inhibitor Formulations in Alzheimer's Disease - Sato_2026_J.Am.Med.Dir.Assoc_27_106481

Author(s) : Sato S , Sasabuchi Y , Yamana H , Kohro T , Yasunaga H

Ref : J Am Med Dir Assoc , 27 :106481 , 2026

Abstract :

PubMedSearch : Sato_2026_J.Am.Med.Dir.Assoc_27_106481

PubMedID: 42691804

Title : 17Beta-estradiol induces down-regulation of Cap43\/NDRG1\/Drg-1, a putative differentiation-related and metastasis suppressor gene, in human breast cancer cells - Fotovati_2006_Clin.Cancer.Res_12_3010

Author(s) : Fotovati A , Fujii T , Yamaguchi M , Kage M , Shirouzu K , Oie S , Basaki Y , Ono M , Yamana H , Kuwano M

Ref : Clin Cancer Research , 12 :3010 , 2006

Abstract :

PubMedSearch : Fotovati_2006_Clin.Cancer.Res_12_3010

PubMedID: 16707596

Gene_locus related to this paper: human-NDRG1

Yamana H

References (2)

1. Treatment Duration of Cholinesterase Inhibitor Formulations in Alzheimer's Disease - Sato_2026_J.Am.Med.Dir.Assoc_27_106481

2. 17Beta-estradiol induces down-regulation of Cap43\/NDRG1\/Drg-1, a putative differentiation-related and metastasis suppressor gene, in human breast cancer cells - Fotovati_2006_Clin.Cancer.Res_12_3010